Found 10 resultsAuthor [ Title] Type Year
Filters: Author is Hayes, P [Clear All Filters]
Assessment of Viral Inhibition Activity in Low Seroprevalent Adenovirus-35 Vectored HIV Vaccines +/- Adjuvanted Protein or Electroporated DNA. In HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P). presented at the 24/09/2014, Cape Town, SA. Retrieved from http://hivr4p.org/. (2014).
Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA-and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing [..] Epitopes. J Virol, 80, 4717-4728. presented at the 05/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16641265. (2006).
Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers. Vaccine, 26(51), 6671-7. presented at the 2008 Dec 02. doi:10.1016/j.vaccine.2008.09.016. (2008).
A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Based on Adeno-Associated Virus. AIDS Res Hum Retroviruses, 26, 933-942. presented at the 08/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20666584. (2010).
Phase 2A Dose and Route Study of a DNA Prime MVA Boost Vaccine Candidate. In AIDS Vaccine 2005 International Conference. presented at the 06/09/2005, Montreal, Quebec, Canada.. (2005).
A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults. PLoS One, 7, e41936. presented at the 08/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22870265. (2012).
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults. PLoS One, 10, e0125954. presented at the 05/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25961283. (2015).
Safety and Immunogenicity Study of Multiclade HIV-1 Adeno-Viral Vector Vaccine Alone or as Boost Following a Multiclade HIV-1 DNA Vaccine in Africa. PLoS ONE, 5, e12873. presented at the 09/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20877623. (2010).
Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of Human Immunodeficiency Virus-1 Vaccine Candidates. J Infect Dis, 201, 720-729. presented at the 03/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20132004. (2010).